用于治疗严重肝硬化而不能手术切除或复发的hcc23目前关于.docVIP

TACE、PEI双介入间隔疗法治疗晚期原发肝细胞癌临床观察 钟立清1， 徐寅聪， 陆龙辉， 孟凡龙 [摘要]目的 对照观察肝动脉化疗栓塞(transact hurter arterial chemoembolization TACE)和经皮肝穿刺注射无水乙醇(combined with percutaneous ethanol injection PEI)间隔双介入疗法治疗晚期原发肝细胞癌(hepatoceiiar car cinoma HCC)临床效果 方法 本组25例采用间隔2周左右时间进行TACE、PEI分别配合治疗，每疗程一般为2-3次TACE、2-4次PEI。对照组为年龄、性别、肿瘤大小及数目、临床分期及肿瘤分型、AFP值、肝功能Child分级无显著性差异(P0.05)的29例单纯进行TACE治疗。两组观察期3年。结果 本组1年、2年、3年内生存率分别为88%（22/25）bservation Of Hepatoceiiar Car Cinoma HCC Of TACE、PEI Treated ZHONG LiQing * , XU yincong,LU longhui ,MENG fanlong The Hospital of The P.L.A 123 rd X-ray depertment,BengBu 233015 Anhui China [Abstract] Purpose Observation of control combined with percutaneous ethanol injection and hepatoceiiar car cinoma HCC Clinical results. Method The group used intervals 25 cases about two weeks time for TACE、 PEI were treated with each course of treatment is generally two to three times TACE ,2-4, PEI. The control group for sex, age, tumor size and number of clinical stage and tumor type, AFP value, liver function Child grading no significant difference (P 0.05) of 29 patients TACE simple for treatment. Two observation period of three years. Results Section 1 of this year, two-year, 3-year survival rates were 88 percent (22/25) 64 percent (16/25) 32 percent (8 / 25) Median survival time was 25.5 months the control group in this group 1 year, two-year, 3-year survival rates were 72 % (21/19)、 31% (9 / 29)、17.2% (5 / 29) Median survival time was 16.5 months. This group than the control group AFP, liver function are a significant improvement. Conclusion TACE, PEI interval than the simple two-intervention therapy TACE treatment of advanced primary treatment of hepatocellular carcinoma increased to extend the survival time of patients, improve the quality of life. [Keywords] Primary hepatocellular carcinoma ；transact hurter arterial chemoembolization ； combined with percutaneous ethanol injection 手术不能切除的晚期原发肝细胞肝癌（hepatoceiiar car cinoma HCC）目前姑息治疗方法是肝动脉化疗栓塞(transact hurter arteria